Savara, Inc. (SVRA)
5.28
+0.24
(+4.76%)
USD |
NASDAQ |
Mar 25, 16:00
5.29
+0.01
(+0.19%)
After-Hours: 20:00
Savara Free Cash Flow : -101.06M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spyre Therapeutics, Inc. | -169.41M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| Imunon, Inc. | -14.95M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.06M |
| Cash from Investing (Quarterly) | -93.56M |
| Cash from Financing (Quarterly) | 135.56M |
| Free Cash Flow Per Share (Quarterly) | -0.1043 |
| Free Cash Flow to Equity (Quarterly) | -25.14M |
| Free Cash Flow to Firm (Quarterly) | -25.06M |
| Free Cash Flow Yield | -8.61% |